- Malignant lymphomas
- Leukemias
- Retinoblastoma
- Carcinoma of breast
- Ovarian cancer
- Mycosis fungoides
- Minimal Change Nephrotic Syndrome in Pediatric Patients
ADCYCLO 50MG
| MRP | : |
|
| Price | : | ₹25.00 |
| You Save | : | ₹10.63 (29.83%) |
10 Tablet(s) In A Strip
Adcyclo 50 Tablet is indicated for the treatment of various malignant conditions, including lymphoma (such as Hodgkin’s disease, mixed-cell type lymphoma, lymphocytic lymphoma, histiocytic lymphoma, multiple myeloma, Burkitt’s lymphoma, and mycosis fungoides), leukaemia, nerve tissue cancer, eye cancer, ovarian cancer, soft tissue cancer, bone cancer, and breast cancer.
Furthermore, Adcyclo 50 Tablet is utilized in managing minimal change nephrotic syndrome (a kidney disorder) in pediatric patients.
The active ingredient in Adcyclo 50 Tablet is Cyclophosphamide, an alkylating agent that interferes with the genetic material of cancer cells, inhibiting their growth and reproduction. Consequently, Adcyclo 50 Tablet aids in cancer treatment by eliminating cancer cells.
It is essential to take Adcyclo 50 Tablet for the duration prescribed by your healthcare provider, based on your specific medical condition. Some patients may encounter common side effects, including fever, nausea, vomiting, diarrhea, hair loss, reduced blood cell count, and abdominal discomfort. If you experience any of these side effects persistently, do not hesitate to consult your doctor.
Avoid using Adcyclo 50 Tablet if you have a known allergy to any of its ingredients, or if you suffer from bladder obstruction or other urinary issues. Pregnant or breastfeeding individuals should refrain from taking Adcyclo 50 Tablet. This medication may induce dizziness; therefore, only drive if you feel fully alert. Adcyclo 50 Tablet should only be administered to children if prescribed by a physician. Be sure to inform your doctor about your health status and any medications you are taking to prevent potential side effects or interactions.
